Tag: Antibody Cocktail

Clinical Trials, Industry, Research and Development, Vaccines

Study of Rare Antibody Cocktail against Lassa Virus Could Bring Clinical Trial Closer

October 27, 2022

Via: GEN

A new study from scientists at La Jolla Institute for Immunology (LJI) has given researchers a guide to neutralizing the deadly Lassa virus (LSV) using a trio of rare antibodies isolated from survivors of Lassa virus infection. The LJI scientists […]

FDA, Regulations

FDA expands use of COVID-19 antibody cocktail

August 3, 2021


The FDA has expanded the use of Regeneron’s antibody cocktail, REGEN-COV, updating its emergency use authorisation (EUA) to include those at high risk of developing severe COVID-19 who have been exposed to the virus. The therapy – a combination of […]

Clinical Trials, Manufacturing, Research and Development

Regeneron Advances Antibody Cocktail into Phase III Trials

July 6, 2020

Via: Genetic Engineering and Biotechnology News

Regeneron Pharmaceuticals said today its double-antibody cocktail against COVID-19 is advancing into Phase III studies, less than a month after the start of its first clinical trial, with preliminary data from one study expected to be reported later this summer. […]